Sep 11, 2018
2:1
For every share held, investors received 2. The price per share adjusted from $3587.80 to $1793.90.
The split itself did not change the total investment value.
GlaxoSmithKline Pharmaceuticals Limited (BSE:GLAXO) operates in the Pharmaceuticals: major industry.
GlaxoSmithKline Pharmaceuticals Limited company overviewGlaxoSmithKline Pharmaceuticals Limited's most recent stock split was on September 11, 2018. It was a 2-for-1 forward split, so shareholders received 2 shares for every share they held.
GlaxoSmithKline Pharmaceuticals Limited (BSE:GLAXO) has split its stock 2 times: a 2-for-1 split on January 2, 1995 and a 2-for-1 split on September 11, 2018.
GlaxoSmithKline Pharmaceuticals Limited has split its stock 2 times. This history records 2 forward splits between January 2, 1995 and September 11, 2018.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In GlaxoSmithKline Pharmaceuticals Limited's 2-for-1 split on September 11, 2018, every share became 2 shares.
GlaxoSmithKline Pharmaceuticals Limited has not announced a new split in our records. Its most recent split was on September 11, 2018, 8 years ago. Companies announce splits in advance, and any new BSE:GLAXO split will appear on this page.
Already premium?